Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

MeSH terms

• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Disease-Free Survival
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Humans
• Immunologic Factors / administration & dosage
• Immunologic Factors / adverse effects*
• Immunologic Factors / therapeutic use
• Multiple Myeloma / drug therapy*
• Nervous System Diseases / chemically induced*
• Neurologic Examination
• Prospective Studies
• Recurrence
• Salvage Therapy*
• Thalidomide / administration & dosage
• Thalidomide / adverse effects*
• Thalidomide / therapeutic use
• Treatment Outcome